Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Net Receivables
$441.80M
Quarterly · Period ending: · USD
BIO Net Receivables
Latest reported$472.50Mperiod ending
Latest reported$472.50Mperiod ending
BIO FY Net Receivables ($23.10M → $472.50M)
Annual net receivables
High-resolution chart · PNG
BIO net receivables history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 472,500,000 | |
| 452,500,000 | |
| 489,000,000 | |
| 494,645,000 | |
| 423,537,000 | |
| 419,424,000 | |
| 392,672,000 | |
| 392,443,000 | |
| 464,847,000 | |
| 372,348,000 | |
| 391,485,000 | |
| 377,640,000 | |
| 422,660,000 | |
| 398,739,000 | |
| 398,674,000 | |
| 387,996,000 | |
| 345,734,000 | |
| 339,653,000 | |
| 358,076,000 | |
| 292,970,000 | |
| 247,192,000 | |
| 261,243,000 | |
| 234,085,000 | |
| 212,282,000 | |
| 194,400,000 | |
| 182,242,000 | |
| 193,900,000 | |
| 106,000,000 | |
| 97,000,000 | |
| 97,800,000 | |
| 92,100,000 | |
| 81,700,000 | |
| 75,800,000 | |
| 76,200,000 | |
| 76,200,000 | |
| 70,500,000 | |
| 59,200,000 | |
| 46,700,000 | |
| 39,400,000 | |
| 28,600,000 | |
| 23,100,000 |